Cti Biopharm Corp
(CTIC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2007 | 12-2006 | 12-2005 | 12-2004 | 12-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -138,108 | -135,819 | -102,505 | -252,298 | -130,031 |
| Depreciation Amortization | 4,955 | 6,430 | 10,278 | 11,434 | 8,440 |
| Accounts receivable | 473 | -383 | -40 | 888 | 814 |
| Accounts payable and accrued liabilities | 4,297 | -2,925 | -3,451 | -1,651 | 1,587 |
| Other Working Capital | 2,264 | 11,496 | -1,285 | -2,120 | 11,397 |
| Other Operating Activity | 22,501 | 4,595 | -28,229 | 95,595 | 649 |
| Operating Cash Flow | $-103,618 | $-116,606 | $-125,232 | $-148,152 | $-107,144 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 34,410 | -17,887 | -8,319 | 71,152 | 35,407 |
| PPE Investments | -1,753 | 5 | -1,763 | -4,632 | -3,335 |
| Net Acquisitions | -11,735 | N/A | 70,417 | -4,969 | -3,981 |
| Other Investing Activity | 555 | 0 | 0 | 92,891 | -3,160 |
| Investing Cash Flow | $21,477 | $-17,882 | $60,335 | $154,442 | $24,931 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 31,174 | 77,704 | 25,000 | 72,143 |
| Debt Repayment | -429 | -2,793 | -41,193 | -2,172 | -1,741 |
| Common Stock Issued | 7,007 | 52,765 | 238 | 66,066 | 2,303 |
| Common Stock Repurchased | N/A | -3,025 | N/A | N/A | N/A |
| Dividend Paid | -395 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 78,517 | 24,617 | -24,600 | 0 | 0 |
| Financing Cash Flow | $84,700 | $102,738 | $12,149 | $88,894 | $72,705 |
| Exchange Rate Effect | -3,890 | -1,143 | -2,263 | 1,411 | N/A |
| Beginning Cash Position | 17,129 | 50,022 | 105,033 | 8,438 | 17,946 |
| End Cash Position | 15,798 | 17,129 | 50,022 | 105,033 | 8,438 |
| Net Cash Flow | $-1,331 | $-32,893 | $-55,011 | $96,595 | $-9,508 |
| Free Cash Flow | |||||
| Operating Cash Flow | -103,618 | -116,606 | -125,232 | -148,152 | -107,144 |
| Capital Expenditure | -1,753 | -534 | -2,016 | -4,632 | -3,335 |
| Free Cash Flow | -105,371 | -117,140 | -127,248 | -152,784 | -110,479 |